Drug-drug Interaction Study With GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The main aim of this study is to investigate the possible effect of GLPG4716 on the
pharmacokinetics (PK) of pirfenidone and nintedanib. Further aims are to investigate safety
and tolerability of GLPG4716 alone or administered simultaneously with pirfenidone or
nintedanib.